Wed, September 22, 2021
Tue, September 21, 2021
Mon, September 20, 2021

Gregory Renza Maintained (VRCA) at Buy with Decreased Target to $16 on, Sep 21st, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-16-on-sep-21st-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Gregory Renza of RBC Capital, Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Buy with Decreased Target from $19 to $16 on, Sep 21st, 2021.

Gregory, nor any peers, have made any analyst calls on VRCA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30